The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
POTELIGEO mogamulizumab 4 mg/mL concentrate for solution for infusion (330232)
ARTG Name
POTELIGEO mogamulizumab 4 mg/mL concentrate for solution for infusion
Product name
POTELIGEO mogamulizumab 4 mg/mL concentrate for solution for infusion vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
mogamulizumab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information